US 11446302
Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations
granted A61KA61K31/436A61K31/517
Quick answer
US patent 11446302 (Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations) held by The Board of Regents of the University of Texas System expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/436, A61K31/517, A61K31/519, A61K31/7088